The valuation of the teleradiology market is estimated to be US$ 7,567.50 million in 2023. The market was valued at US$ 6,489.20 million in 2022. The market is projected to show outstanding growth over the forecast period, expanding at a CAGR of 18.4% through 2033. The size of the market is predicted to reach US$ 40,873.30 million by 2033.
Consumption Analysis of the Teleradiology Market
Attributes | Details |
---|---|
Teleradiology Market Value in 2023 | US$ 7,567.50 million |
Projected Market Value by 2033 | US$ 40,873.30 million |
Value-based CAGR from 2023 to 2033 | 18.4% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The size of the teleradiology market was US$ 2,865.00 million in 2018. The market progressed at a CAGR of 22.0% during the historical period from 2018 to 2022.
The adoption of teleradiology into healthcare procedures is expected to rise during the historical period. The pandemic highlighted the need for teleradiology as there were restrictions on travel. The pandemic period also led to an increased number of patients. To manage the load of patients, doctors resorted to teleradiology. The market value reached US$ 6,489.20 million in 2022.
Market Value (2018) | US$ 2,865.00 million |
---|---|
Historical CAGR (2018 to 2022) | 22.0% |
Historical Market Valuation (2022) | US$ 6,489.20 million |
Long-Term Analysis of the Teleradiology Market
The teleradiology market is estimated to be worth US$ 7,567.50 million in 2023. The market is expected to grow at an exceptional CAGR of 18.4% through 2033.
The market's progress over the forecast period is anticipated to be slower than the historical period. The pandemic influenced monumental growth in the historical period. However, the market is still slated to be lucrative during the historical period due to the increasing acceptance of teleradiology.
The incidence of diseases that require diagnostic testing is rising, and thus, there is more demand for diagnostic equipment. The rising demand for diagnostic equipment also leads to the growth of the teleradiology market. As online communication becomes more popular, the virtual travel of information is becoming the norm in many industries. Teleradiology is one way through which the healthcare industry is embracing digitalization. By 2033, the market is projected to reach a valuation of US$ 40,873.30 million.
In addition to the teleradiology market, two related markets have been discussed in the section below. One is closely tied to the teleradiology market, while the other is related to medical imaging. These markets are the teleradiology service market and the specific imaging solution market.
By analyzing the three markets in conjunction, the positive trend of healthcare technologies can be observed. The rapid progress of technology in the healthcare sector is a common trend observed.
Teleradiology Market:
Attributes | Teleradiology Market |
---|---|
Value-based CAGR (2023 to 2033) | 18.4% |
Projected Market Value (2033) | US$ 40,873.30 million |
Market Trends |
|
Growth Factors |
|
Teleradiology Service Market:
Attributes | Teleradiology Service Market |
---|---|
Value-based CAGR (2023 to 2033) | 12.2% |
Projected Market Value (2033) | US$ 22,069.5 million |
Market Trends |
|
Growth Factors |
|
Specific Imaging Solution Market:
Attributes | Specific Imaging Solution Market |
---|---|
Value-based CAGR (2023 to 2033) | 6.5% |
Projected Market Value (2033) | US$ 756.3 Million |
Market Trends |
|
Growth Factors |
|
The X-ray technique has emerged as the top scan type in the market. The X-ray segment is expected to account for 23.1% of the market share by modality in 2023.
CT scans ruled the market by modality, especially during the pandemic when issues such as heart problems had increased. However, X-ray scans have gradually overtaken CT scans and are now most routinely used in teleradiology.
Attributes | Details |
---|---|
Top Modality | X-rays |
Market Share in 2023 | 23.1% |
Scans of the brain are the most popular application of teleradiology. The brain segment is anticipated to hold 28.2% of the market share in 2023.
Scans of the brain include computed tomography (CT), magnetic resonance imaging (MRI), and positive emission tomography (PET). As the incidence of brain problems continues, the need for scans increases.
Attributes | Details |
---|---|
Top Organ | Brain |
Market Share in 2023 | 28.2% |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The Asia Pacific is marked for exponential growth in the market. The rising population in the region is leading to an increase in the number of healthcare institutions. However, in-person healthcare is not always practical. As such, medical professionals in Asia Pacific are resorting to teleradiology to contend with the increasing need for medical scans.
North America and Europe are other lucrative regions in the market; though the pace of progress in the two regions is estimated to be lower than in Asia Pacific, still significant opportunities are present.
Countries | CAGR (2023 to 2033) |
---|---|
United States | 8.3% |
China | 23.9% |
United Kingdom | 11.9% |
Germany | 11.0% |
India | 27.6% |
The United States holds a significant market share and is expected to progress at a CAGR of 8.3% through 2033.
The healthcare infrastructure in the United States is growing, and imaging procedures of various kinds are performed regularly in the United States. Thus, the teleradiology market benefits and is projected to thrive in the United States.
The United Kingdom is one of the most promising countries in the European market. The CAGR for the United Kingdom market is anticipated to be 11.9% through 2033.
There are a high number of professionals working in the radiology field in the United Kingdom. Thus, radiology equipment and scans are commonplace in the country. Teleradiology, too, is flourishing in the United Kingdom.
Germany is another European country with significant potential for market growth. The CAGR for Germany is estimated to be 11.0% from 2023 to 2033.
With the rising aging population in Germany, there is an increasing demand for medical equipment. As the number of people afflicted with various problems rises in Germany, so does the need for scans.
India is one of the fastest-growing countries in the market. Over the forecast period, the CAGR for the market in India is projected to be 27.6%.
India is one of the most populous countries in the world. However, a significant portion of the population resides in rural areas, where a shortage of skilled medical personnel is often felt. To make up for the lack of experts in rural areas, the help of teleradiology is highly sought in India.
China is another Asian country filled with the potential for market growth. The market in China is expected to grow at a CAGR of 23.9% over the forecast years.
The introduction of cloud-based teleradiology has transformed the market in China. Several healthcare facilities in China are accepting teleradiology backed by cloud computing into the fold. Thus, China is a lucrative market for teleradiology.
The market is dominated by a few big players. For the companies in the market, innovation is the name of the game. The market players are integrating such advanced technologies like AI and advanced compressing.
While there are a few dominant players in the market, startups are also striving to make room. The initiatives of the startups are often helped by government aid.
Recent Developments in the Teleradiology Market
The size of the teleradiology market in 2023 is expected to be US$ 7,567.50 million.
By 2033, the size of the teleradiology market will be US$ 40,873.30 million.
For the forecast period from 2023 to 2033, the teleradiology market in India is expected to progress at an incredible CAGR of 27.6%.
The teleradiology market is expected to grow at a healthy CAGR of 8.3% from 2023 to 2033 in the United States.
Cerner Corporation, Siemens Healthineers, McKesson Corporation, and Agfa Healthcare are some of the prominent companies in the market.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Modality 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Modality, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Modality, 2023 to 2033 5.3.1. X-Ray Scans 5.3.2. CT Scans 5.3.3. MRI Scans 5.3.4. Ultrasound Scans 5.3.5. Nuclear Scan 5.3.6. Cardiac Echo 5.3.7. Mammography 5.3.8. Electromyography 5.4. Y-o-Y Growth Trend Analysis By Modality, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Modality, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033 6.3.1. Hospitals 6.3.2. Clinics 6.3.3. Ambulatory Surgical Centres 6.3.4. Radiology Centres 6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 7.3.1. North America 7.3.2. Latin America 7.3.3. Western Europe 7.3.4. Eastern Europe 7.3.5. South Asia and Pacific 7.3.6. East Asia 7.3.7. Middle East and Africa 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 8.2.1. By Country 8.2.1.1. USA 8.2.1.2. Canada 8.2.2. By Modality 8.2.3. By End User 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Modality 8.3.3. By End User 8.4. Key Takeaways 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Modality 9.2.3. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Modality 9.3.3. By End User 9.4. Key Takeaways 10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. UK 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Western Europe 10.2.2. By Modality 10.2.3. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Modality 10.3.3. By End User 10.4. Key Takeaways 11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Poland 11.2.1.2. Russia 11.2.1.3. Czech Republic 11.2.1.4. Romania 11.2.1.5. Rest of Eastern Europe 11.2.2. By Modality 11.2.3. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Modality 11.3.3. By End User 11.4. Key Takeaways 12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Bangladesh 12.2.1.3. Australia 12.2.1.4. New Zealand 12.2.1.5. Rest of South Asia and Pacific 12.2.2. By Modality 12.2.3. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Modality 12.3.3. By End User 12.4. Key Takeaways 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Modality 13.2.3. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Modality 13.3.3. By End User 13.4. Key Takeaways 14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. South Africa 14.2.1.3. Israel 14.2.1.4. Rest of MEA 14.2.2. By Modality 14.2.3. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Modality 14.3.3. By End User 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. USA 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2022 15.1.2.1. By Modality 15.1.2.2. By End User 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2022 15.2.2.1. By Modality 15.2.2.2. By End User 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2022 15.3.2.1. By Modality 15.3.2.2. By End User 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2022 15.4.2.1. By Modality 15.4.2.2. By End User 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2022 15.5.2.1. By Modality 15.5.2.2. By End User 15.6. UK 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2022 15.6.2.1. By Modality 15.6.2.2. By End User 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2022 15.7.2.1. By Modality 15.7.2.2. By End User 15.8. Spain 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2022 15.8.2.1. By Modality 15.8.2.2. By End User 15.9. Italy 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2022 15.9.2.1. By Modality 15.9.2.2. By End User 15.10. Poland 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2022 15.10.2.1. By Modality 15.10.2.2. By End User 15.11. Russia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2022 15.11.2.1. By Modality 15.11.2.2. By End User 15.12. Czech Republic 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2022 15.12.2.1. By Modality 15.12.2.2. By End User 15.13. Romania 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2022 15.13.2.1. By Modality 15.13.2.2. By End User 15.14. India 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2022 15.14.2.1. By Modality 15.14.2.2. By End User 15.15. Bangladesh 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2022 15.15.2.1. By Modality 15.15.2.2. By End User 15.16. Australia 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2022 15.16.2.1. By Modality 15.16.2.2. By End User 15.17. New Zealand 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2022 15.17.2.1. By Modality 15.17.2.2. By End User 15.18. China 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2022 15.18.2.1. By Modality 15.18.2.2. By End User 15.19. Japan 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2022 15.19.2.1. By Modality 15.19.2.2. By End User 15.20. South Korea 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2022 15.20.2.1. By Modality 15.20.2.2. By End User 15.21. GCC Countries 15.21.1. Pricing Analysis 15.21.2. Market Share Analysis, 2022 15.21.2.1. By Modality 15.21.2.2. By End User 15.22. South Africa 15.22.1. Pricing Analysis 15.22.2. Market Share Analysis, 2022 15.22.2.1. By Modality 15.22.2.2. By End User 15.23. Israel 15.23.1. Pricing Analysis 15.23.2. Market Share Analysis, 2022 15.23.2.1. By Modality 15.23.2.2. By End User 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Modality 16.3.3. By End User 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Cerner Corporation 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.2. Siemens Healthineers 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.3. McKesson Corporation 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.4. Agfa Healthcare 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.5. MEDNAX Services, Inc. 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.6. ONRAD Inc. 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.7. Novarad Corporation 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.8. TeleDiagnostic Solutions Pvt. Ltd. 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.9. Solutions 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.10. Telerad Tech 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 17.1.11. StatRad LLC 17.1.11.1. Overview 17.1.11.2. Product Portfolio 17.1.11.3. Profitability by Market Segments 17.1.11.4. Sales Footprint 17.1.11.5. Strategy Overview 17.1.11.5.1. Marketing Strategy 17.1.12. MedWeb LLC 17.1.12.1. Overview 17.1.12.2. Product Portfolio 17.1.12.3. Profitability by Market Segments 17.1.12.4. Sales Footprint 17.1.12.5. Strategy Overview 17.1.12.5.1. Marketing Strategy 17.1.13. USARAD Holdings, Inc. 17.1.13.1. Overview 17.1.13.2. Product Portfolio 17.1.13.3. Profitability by Market Segments 17.1.13.4. Sales Footprint 17.1.13.5. Strategy Overview 17.1.13.5.1. Marketing Strategy 17.1.14. Everlight Radiology 17.1.14.1. Overview 17.1.14.2. Product Portfolio 17.1.14.3. Profitability by Market Segments 17.1.14.4. Sales Footprint 17.1.14.5. Strategy Overview 17.1.14.5.1. Marketing Strategy 17.1.15. SRL Diagnostics, 17.1.15.1. Overview 17.1.15.2. Product Portfolio 17.1.15.3. Profitability by Market Segments 17.1.15.4. Sales Footprint 17.1.15.5. Strategy Overview 17.1.15.5.1. Marketing Strategy 17.1.16. Vital Radiology Services 17.1.16.1. Overview 17.1.16.2. Product Portfolio 17.1.16.3. Profitability by Market Segments 17.1.16.4. Sales Footprint 17.1.16.5. Strategy Overview 17.1.16.5.1. Marketing Strategy 17.1.17. Telemedicine Clinic. 17.1.17.1. Overview 17.1.17.2. Product Portfolio 17.1.17.3. Profitability by Market Segments 17.1.17.4. Sales Footprint 17.1.17.5. Strategy Overview 17.1.17.5.1. Marketing Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports